1. Home
  2. MCRB vs APYX Comparison

MCRB vs APYX Comparison

Compare MCRB & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCRB
  • APYX
  • Stock Information
  • Founded
  • MCRB 2010
  • APYX 1982
  • Country
  • MCRB United States
  • APYX United States
  • Employees
  • MCRB N/A
  • APYX N/A
  • Industry
  • MCRB Biotechnology: Pharmaceutical Preparations
  • APYX Medical/Dental Instruments
  • Sector
  • MCRB Health Care
  • APYX Health Care
  • Exchange
  • MCRB Nasdaq
  • APYX Nasdaq
  • Market Cap
  • MCRB 72.0M
  • APYX 66.5M
  • IPO Year
  • MCRB 2015
  • APYX 1987
  • Fundamental
  • Price
  • MCRB $7.63
  • APYX $1.99
  • Analyst Decision
  • MCRB Hold
  • APYX Hold
  • Analyst Count
  • MCRB 4
  • APYX 2
  • Target Price
  • MCRB $73.67
  • APYX N/A
  • AVG Volume (30 Days)
  • MCRB 75.0K
  • APYX 64.5K
  • Earning Date
  • MCRB 08-12-2025
  • APYX 08-07-2025
  • Dividend Yield
  • MCRB N/A
  • APYX N/A
  • EPS Growth
  • MCRB N/A
  • APYX N/A
  • EPS
  • MCRB 8.98
  • APYX N/A
  • Revenue
  • MCRB N/A
  • APYX $47,288,000.00
  • Revenue This Year
  • MCRB N/A
  • APYX $2.25
  • Revenue Next Year
  • MCRB N/A
  • APYX $6.76
  • P/E Ratio
  • MCRB $0.89
  • APYX N/A
  • Revenue Growth
  • MCRB N/A
  • APYX N/A
  • 52 Week Low
  • MCRB $6.53
  • APYX $0.76
  • 52 Week High
  • MCRB $30.60
  • APYX $2.06
  • Technical
  • Relative Strength Index (RSI)
  • MCRB 48.66
  • APYX 62.71
  • Support Level
  • MCRB $7.25
  • APYX $1.70
  • Resistance Level
  • MCRB $7.89
  • APYX $2.06
  • Average True Range (ATR)
  • MCRB 0.46
  • APYX 0.17
  • MACD
  • MCRB 0.11
  • APYX -0.01
  • Stochastic Oscillator
  • MCRB 60.23
  • APYX 70.72

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Share on Social Networks: